Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic

Stem Cell Research

Volumn 6, Issue 3, 2011, Pages 215-225

  Oskowitz, Adam ^a   McFerrin, Harris ^a   Gutschow, Miriam ^a   Carter, Mary Leita ^a   Pochampally, Radhika ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; CD11B ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HERMES ANTIGEN; SCATTER FACTOR; SOMATOMEDIN C; THY 1 ANTIGEN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; MESENCHYME CELL; MICROTUBULE; MULTIPOTENT STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERUM; STROMA CELL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; AORTA; CELL DIFFERENTIATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; HUMANS; MULTIPOTENT STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; STROMAL CELLS;

RATTUS;

EID: 79954988933     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2011.01.004     Document Type: Article

References (32)

1. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
2. Owen M., Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 1988, 136:42-60.
3. Dominici M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 3. Cytotherapy 2006, 8:315-317.
4. Kocher A.A., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7:430-436.
5. Kinnaird T., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
6. Iwase T., et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc. Res. 2005, 66:543-551.
7. Al-Khaldi A., Al-Sabti H., Galipeau J., Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann. Thorac. Surg. 2003, 75:204-209.
8. Lee R.H., et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl Acad. Sci. USA 2006, 103:17438-17443.
9. Gnecchi M., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 2005, 11:367-368.
10. Chopp M., Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 2002, 1:92-100.
11. Karnoub A.E., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
12. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
13. Sasaki M., et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. 2008, 180:2581-2587.
14. Phinney D.G., Prockop D.J. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007, 25:2896-2902.
15. Wang M., Crisostomo P.R., Herring C., Meldrum K.K., Meldrum D.R. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R880-R884.
16. Pochampally R.R., Smith J.R., Ylostalo J., Prockop D.J. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 2004, 103:1647-1652.
17. Aoki M., et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther. 2000, 7:417-427.
18. Urbanek K., et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res. 2005, 97:663-673.
19. Auerbach R., Lewis R., Shinners B., Kubai L., Akhtar N. Angiogenesis assays: a critical overview. Clin. Chem. 2003, 49:32-40.
20. Voyta J.C., Via D.P., Butterfield C.E., Zetter B.R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 1984, 99:2034-2040.
21. Luesch H., et al. A functional genomics approach to the mode of action of apratoxin A. Nat. Chem. Biol. 2006, 2:158-167.
22. Sacchetti B., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
23. Bianco P., Robey P.G. Stem cells in tissue engineering. Nature 2001, 414:118-121.
24. Ylostalo J., Bazhanov N., Prockop D.J. Reversible commitment to differentiation by human multipotent mesenchymal stem cells (MSCs) in single-cell derived colonies. Exp. Hematol. 2008, 36(10):1390-1402.
25. Hung S.C., Pochampally R.R., Chen S.C., Hsu S.C., Prockop D.J. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007, 25:2363-2370.
26. Sadat S., et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun. 2007, 363:674-679.
27. Matsumoto R., et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1168-1173.
28. Shim W.S., et al. Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model. J. Biomed. Sci. 2006, 13:579-591.
29. Oswald J., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004, 22:377-384.
30. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
31. Kabrun N., et al. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 1997, 124:2039-2048.
32. Nishikawa S.I., Nishikawa S., Hirashima M., Matsuyoshi N., Kodama H. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+cells at a diverging point of endothelial and hemopoietic lineages. Development 1998, 125:1747-1757.